Biomedical Engineering Reference
In-Depth Information
Iakoubova OA, Tong CH, Rowland CM, et al. Association of the Trp719Arg polymorphism in
kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective
trials: the CARE and WOSCOPS trials. J Am Coll Cardiol 2008;51:435-43.
Jain KK. Textbook of Personalized Medicine. Springer, New York, 2009.
Jain KK. Personalized Medicine: scientific & commercial aspects. Jain PharmaBiotech, Basel,
Switzerland, 2011.
Johnson JA, Boerwinkle E, Zineh I, et al. Pharmacogenomics of antihypertensive drugs: rationale
and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
Am Heart J 2009;157:442-9.
Judson R, Brain C, Dain B, et al. New and confirmatory evidence of an association between APOE
genotype and baseline C-reactive protein in dyslipidemic individuals. Atherosclerosis
2004;177:345-51.
Kathiresan S, Melander O, Anevski D, et al. Polymorphisms Associated with Cholesterol and
Risk of Cardiovascular Events. NEJM 2008;358:1240-1249.
Koenig W, Khuseyinova N, Lowel H, et al. Lipoprotein-associated phospholipase A2 adds to risk
prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged
men from the general population: results from the 14-year follow-up of a large cohort from
southern Germany. Circulation 2004;110:1903-8.
Kunnas TA, Ilveskoski E, Niskakangas T, et al. Association of the endothelial nitric oxide syn-
thase gene polymorphism with risk of coronary artery disease and myocardial infarction in
middle-aged men. J Mol Med 2002a;80:605-9.
Kunnas TA, Lehtimaki T, Laaksonen R, et al. Endothelial nitric oxide synthase genotype modu-
lates the improvement of coronary blood flow by pravastatin: a placebo-controlled PET study.
J Mol Med 2002b;80:802-7.
Lanzani C, Citterio L, Glorioso N, et al. Adducin- and Ouabain-Related Gene Variants Predict the
Antihypertensive Activity of Rostafuroxin, Part 2: Clinical Studies. Sci Transl Med 2010;
2:59ra87.
Liggett SB, Mialet-Perez J, Thaneemit-Chen S, et al. A polymorphism within a conserved beta(1)-
adrenergic receptor motif alters cardiac function and beta-blocker response in human heart
failure. PNAS 2006;103:11288-93.
Ordovas JM, Shen H. Pharmacogenetics of Lipid-lowering Therapies. Curr Atheroscler Rep
2002;4:183-92.
Polisecki E, Muallem H, Maeda N, et al; on behalf of the Prospective Study of Pravastatin in the
Elderly at Risk (PROSPER) Investigators. Genetic variation at the LDL receptor and HMG-
CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in
PROSPER. Atherosclerosis 2008;200:109-14.
Romanoski CE, Lee S, Kim MJ, et al. Systems Genetics Analysis of Gene-by-Environment
Interactions in Human Cells. Amer J Hum Genet 2010;86:399-410.
Rost S, Fregin A, Ivaskevicius V, et al. Mutations in VKORC1 cause warfarin resistance and
multiple coagulation factor deficiency type 2. Nature 2004;427:537-41.
Shiffman D, Chasman DI, Zee RY, et al. A kinesin family member 6 variant is associated with
coronary heart disease in the Women's Health Study. J Am Coll Cardiol 2008;51:444-8.
Siest G, Marteau JB, Maumus S, et al. Pharmacogenomics and pharmacoproteomics: a strategy
for cardio-vascular drugs. Ann Pharm Fr 2007;65:203-10.
Taylor AL, Ziesche S, Yancy C, et al. Combination of Isosorbide Dinitrate and Hydralazine in
Blacks with Heart Failure. NEJM 2004;351:2049-2057.
Terra SG, Pauly DF, Lee CR, et al. beta-Adrenergic receptor polymorphisms and responses during
titration of metoprolol controlled release/extended release in heart failure. Clin Pharmacol
Ther 2005;77:127-37.
Vermes A, Vermes I. Genetic polymorphisms in cytochrome P450 enzymes: effect on efficacy and
tolerability of HMG-CoA reductase inhibitors. Am J Cardiovasc Drugs 2004;4:247-55.
Voora D, Shah SH, Reed CR, et al. Pharmacogenetic Predictors of Statin-Mediated Low-Density
Lipoprotein Cholesterol Reduction and Dose Response. Circulation: Cardiovascular Genetics
2008;1:100-106.
Wickline SA, Neubauer AM, Winter P, et al. Applications of nanotechnology to atherosclerosis,
thrombosis, and vascular biology. Arterioscler Thromb Vasc Biol 2006;26:435-41.